ATE390122T1 - Universelle zusammensetzung zur kontrollierten wirkstofffreigabe enthaltend xanthangummi und natriumalginat - Google Patents
Universelle zusammensetzung zur kontrollierten wirkstofffreigabe enthaltend xanthangummi und natriumalginatInfo
- Publication number
- ATE390122T1 ATE390122T1 AT03019531T AT03019531T ATE390122T1 AT E390122 T1 ATE390122 T1 AT E390122T1 AT 03019531 T AT03019531 T AT 03019531T AT 03019531 T AT03019531 T AT 03019531T AT E390122 T1 ATE390122 T1 AT E390122T1
- Authority
- AT
- Austria
- Prior art keywords
- sodium alginate
- gummi
- active ingredients
- controlled release
- ingredients containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03019531A EP1510205B1 (de) | 2003-09-01 | 2003-09-01 | Universelle Zusammensetzung zur kontrollierten Wirkstofffreigabe enthaltend Xanthangummi und Natriumalginat |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE390122T1 true ATE390122T1 (de) | 2008-04-15 |
Family
ID=34089635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03019531T ATE390122T1 (de) | 2003-09-01 | 2003-09-01 | Universelle zusammensetzung zur kontrollierten wirkstofffreigabe enthaltend xanthangummi und natriumalginat |
Country Status (5)
Country | Link |
---|---|
US (1) | US20050074491A1 (de) |
EP (1) | EP1510205B1 (de) |
JP (1) | JP2005075830A (de) |
AT (1) | ATE390122T1 (de) |
DE (1) | DE60319982T2 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101612140B (zh) * | 2009-07-13 | 2011-12-14 | 浙江金华康恩贝生物制药有限公司 | 一种双氯芬酸钾缓释微丸胶囊的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
US4867970A (en) * | 1987-05-21 | 1989-09-19 | E. R. Squibb & Sons, Inc. | Moistureless oral drug delivery formulation and method for preparing same |
US4994276A (en) * | 1988-09-19 | 1991-02-19 | Edward Mendell Co., Inc. | Directly compressible sustained release excipient |
US5558876A (en) * | 1995-03-29 | 1996-09-24 | Alcon Laboratories, Inc. | Topical ophthalmic acidic drug formulations |
IN186245B (de) * | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
AU2001227030A1 (en) * | 2000-11-22 | 2002-06-03 | Lupin Laboratories Limited | Pharmaceutical composition for controlled release of an active ingredient |
-
2003
- 2003-09-01 AT AT03019531T patent/ATE390122T1/de not_active IP Right Cessation
- 2003-09-01 EP EP03019531A patent/EP1510205B1/de not_active Expired - Lifetime
- 2003-09-01 DE DE60319982T patent/DE60319982T2/de not_active Expired - Fee Related
-
2004
- 2004-08-27 US US10/928,508 patent/US20050074491A1/en not_active Abandoned
- 2004-09-01 JP JP2004253850A patent/JP2005075830A/ja not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60319982D1 (de) | 2008-05-08 |
US20050074491A1 (en) | 2005-04-07 |
EP1510205A1 (de) | 2005-03-02 |
EP1510205B1 (de) | 2008-03-26 |
DE60319982T2 (de) | 2009-04-16 |
JP2005075830A (ja) | 2005-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2004137118A (ru) | Фармацевтическая композиция для контролируемого высвобождения активных веществ и способ ее изготовления | |
JP5934812B2 (ja) | 制御放出の製剤処方または食品処方およびその製造方法 | |
MX2008000099A (es) | Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones. | |
BRPI0409336A (pt) | sistema de liberação compreendendo uma pelìcula de gel termorreversìvel, homogênea, pelìcula de sistema de liberação, e, processo para preparar o sistema de liberação da mesma | |
WO2003074086A1 (fr) | Matrice liquide a transfert de phase in vivo, et preparations liquides orales | |
BR0307893A (pt) | Formulação oftálmica com sistema de goma | |
EA200702520A1 (ru) | Составы для изменения биофизических свойств слизистой оболочки | |
NO20071853L (no) | Farmasoytisk sammensetning inneholdende en fast dispersjon med en polymermatriks inneholdende en jevn polydekstrosefase og en jevn fase av en polymer forskjellig fra polydekstrose. | |
JP2009185083A (ja) | ドロキシドパを含有する安定な錠剤 | |
ATE493973T1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
BR0307278A (pt) | Formulação oral de liberação imediata, e, método para preparar uma formulação | |
CY1108863T1 (el) | Φαρμακευτικο σκευασμα εκτεταμενης απελευθερωσης ανεξαρτητης απο το ρη | |
TN2009000197A1 (en) | Sustained - release composition and method for producing the same | |
JP2007119552A (ja) | (メタ)アクリル酸系含水ゲル体の製造方法および(メタ)アクリル酸系含水ゲル | |
JP2006321792A (ja) | 含水ゲル体及びその製造方法 | |
JPS63174924A (ja) | 軟膏基剤および軟膏剤 | |
PE20020207A1 (es) | Preparaciones de liberacion controlada que comprenden derivados de quinolona y polimeros | |
EP1986693A1 (de) | Basenbildendes wirkstoffbeschichtetes silikathybrid mit basischem polymer und dessen syntheseverfahren | |
HUP0400799A2 (hu) | Fedett ízű gyógyszerészeti készítmény és eljárás előállítására | |
DE60319983D1 (de) | Universelle Zusammensetzung zur kontrollierten Wirkstoffabgabe enthaltend Chitosan | |
ATE390122T1 (de) | Universelle zusammensetzung zur kontrollierten wirkstofffreigabe enthaltend xanthangummi und natriumalginat | |
DK1305057T3 (da) | Mikropartikelformig biomaterialesammensætning af hyaluronsyre til medicinsk anvendelse | |
ES2259011T3 (es) | Composicion farmaceutica para la liberacion controlada de un antibiotico beta-lactama. | |
KR20080080318A (ko) | 지용성 약물을 함유하는 구강내 속붕정 | |
JP2009096793A (ja) | プラノプロフェン含有水性医薬組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |